Inhibitor-conjugated harmonic nanoparticles targeting fibroblast activation protein

Raphaël De Matos(École Polytechnique Fédérale de Lausanne), Sandrine Gerber‐Lemaire(École Polytechnique Fédérale de Lausanne), Davide Staedler(University of Lausanne), Christophe Mas(Debiopharm (Switzerland)), Samuel Constant(Exelixis (United States)), Jérémy Vuilleumier(École Polytechnique Fédérale de Lausanne)
RSC Advances
January 1, 2019
Cited by 8


Related Papers